181
Participants
Start Date
March 31, 2012
Primary Completion Date
December 31, 2014
Study Completion Date
March 31, 2015
BM32
Subcutaneous injection of 20 micrograms of each of the protein components of BM32 adsorbed on 0.6 mg of aluminum hydroxide every 4 weeks for a total of 3 injections before each pollen season and one boost injection after pollen season
BM32
Subcutaneous injection of 40 micrograms of each of the protein components of BM32 adsorbed on 1.2 mg of aluminum hydroxide every 4 weeks for a total of 3 injections before each pollen season and one boost injection after pollen season
Placebo
Subcutaneous injection of 1.2 mg of aluminum hydroxide suspension every four weeks before each pollen season and one injection after pollen season for a total of 7 injections
Medical University, Vienna
Dept. of Internal Medicine Erasmus Medical Center, Rotterdam
University Clinic of Respiratory and Allergic Diseases Golnik, Golnik
Universitätsklinik für Dermatologie und Allergologie, Graz
Allergy Network Ghent University Hospital Ghent, Dept. Otorhiolaryngologie, Ghent
Allergiezentrum Charite, Berlin
Dept. of Dermatology and Allergology University Medical Center Gieseen and Mrbaurg GmbH, Marburg
Klinik und Poliklnik für Dermatologie und Allergologie der Universität Bonn, Bonn
Zentrum für Rhinologie/Allergologie, Wiesbaden
Department of Dermatology and Allergology Am Biederstein TU Munich, Munich
Allergy Clinic Copenhagen University Hospital at Gentofte, Hellerup
Lead Sponsor
Biomay AG
INDUSTRY